Azurity Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Azurity Pharmaceuticals's estimated annual revenue is currently $97.5M per year.
- Azurity Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Azurity Pharmaceuticals has 485 Employees.
- Azurity Pharmaceuticals grew their employee count by 25% last year.
Azurity Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Executive Director, National Accounts | Reveal Email/Phone |
3 | VP Supply Chain | Reveal Email/Phone |
4 | VP Technical Operations at Azurity Pharmaceuticals | Reveal Email/Phone |
5 | VP Manufacturing | Reveal Email/Phone |
6 | VP Regulatory Affairs | Reveal Email/Phone |
7 | VP, Marketing | Reveal Email/Phone |
8 | VP Marketing | Reveal Email/Phone |
9 | VP Quality | Reveal Email/Phone |
10 | General Counsel & Corporate Secretary | Reveal Email/Phone |
Azurity Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is Azurity Pharmaceuticals?
Azurity’s mission is to make safe, high-quality treatments for patients who require formulations of drugs other than what is commonly commercially available (such as tablets and capsules).
keywords:N/AN/A
Total Funding
485
Number of Employees
$97.5M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Azurity Pharmaceuticals News
2022-04-17 - NovaQuest's Arbor, Comar Sue Amneal to Block Copies of ...
NovaQuest Capital's Azurity Pharmaceuticals Inc., its Arbor unit, and their business partner, Morgan Stanley's Comar LLC, filed a lawsuit...
2022-04-17 - Mycosis Fungoides Therapeutics Market Size 2022-2029| Key ...
Azurity Pharmaceuticals Inc. Celgene Corp. Eisai Co. Ltd. Helsinn Healthcare SA; Horizon Therapeutics Plc; Kyowa Kirin Co. Ltd. Merck & Co.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $172.5M | 511 | 5% | N/A |
#2 | $111.8M | 511 | 5% | N/A |
#3 | $108.2M | 597 | 9% | N/A |
#4 | $157.5M | 776 | 3% | N/A |
#5 | $351.4M | 815 | 24% | N/A |